Poster Session Abstracts

Abstract P5-02-03: Evaluating the feasibility of a web-based preference-tolerant randomized trial of risk-based vs. annual breast cancer screening: WISDOM study pilot.

Poster Session Abstracts

A Stover Fiscalini, S Theiner, C Kaplan, S Sarrafan, S Sawyer, A Liang, S Rosenberg-Wohl, D Gordon, M Frick, A Borowsky, H Anton-Culver, A Naeim, A LaCroix, T Cink, L Esserman, L van 't Veer

Abstract P6-02-08: Breast cancer screening in the precision medicine era.

Poster Session Abstracts

CK Thompson, AS Fiscalini, P Donnellan, CP Kaplan, L Madlensky, M Eklund, E Ziv, LJ van't Veer, JA Tice, LJ Esserman

Abstract P3-10-01: A pilot feasibility study of the WISDOM study, a preference-tolerant randomized controlled trial evaluating a risk-based breast cancer screening strategy.

Poster Session Abstracts

PR Narasimmaraj, A Stover Fiscalini, CP Kaplan, LJ van't Veer, AM Hallada, CK Thompson, S Theiner, A Borowsky, A Naeim, H Anton-Culver, A LaCroix, LJ Esserman

Abstract P6-09-10: The comparison of the distribution of breast cancer risk factor between Chinese women, non-Chinese Asian and Caucasian women in the screening cohort of Athena Breast Health Network.

Poster Session Abstracts

Bo Pan, Jeffrey Tice, Qiang Sun, Celia Kaplan, Zhou Yidong, Yali Xu, Songjie Shen, Changjun Wang, Alexandra Solomon, Lauren Ryan, Paige Kendall, Timothy Henderson, Laura Esserman, Beth Crawford, Athena Breast Health Network, Laura van 't Veer

Abstract P4-13-13: Risk Assessment and Personalized Decision Support: The University of California Athena Breast Health Network.

Poster Session Abstracts

EM Ozanne, B Crawford, A Petruse, L Madlensky, L Weiss, M Hogarth, N Wenger, D Goodman, H Park, H Anton-Culver, S Yasmeen, L Howell, H Ojeda, BA Parker, C Kaplan, Veer L van't, L Esserman, A Naeim